191 related articles for article (PubMed ID: 19557370)
1. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.
Kim SH; Choi SJ; Kim YC; Kuh HJ
Arch Pharm Res; 2009 Jun; 32(6):915-22. PubMed ID: 19557370
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of novel indirubin derivatives in rat tumor model.
Kim SA; Kim YC; Kim SW; Lee SH; Min JJ; Ahn SG; Yoon JH
Clin Cancer Res; 2007 Jan; 13(1):253-9. PubMed ID: 17200363
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.
Moon MJ; Lee SK; Lee JW; Song WK; Kim SW; Kim JI; Cho C; Choi SJ; Kim YC
Bioorg Med Chem; 2006 Jan; 14(1):237-46. PubMed ID: 16182537
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
5. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
[TBL] [Abstract][Full Text] [Related]
6. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.
Lee JW; Moon MJ; Min HY; Chung HJ; Park EJ; Park HJ; Hong JY; Kim YC; Lee SK
Bioorg Med Chem Lett; 2005 Sep; 15(17):3948-52. PubMed ID: 15993584
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.
Kritsanida M; Magiatis P; Skaltsounis AL; Peng Y; Li P; Wennogle LP
J Nat Prod; 2009 Dec; 72(12):2199-202. PubMed ID: 19994845
[TBL] [Abstract][Full Text] [Related]
10. 5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.
Choi SJ; Lee JE; Jeong SY; Im I; Lee SD; Lee EJ; Lee SK; Kwon SM; Ahn SG; Yoon JH; Han SY; Kim JI; Kim YC
J Med Chem; 2010 May; 53(9):3696-706. PubMed ID: 20361800
[TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction.
Varela AT; Gomes AP; Simões AM; Teodoro JS; Duarte FV; Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2008 Dec; 233(2):179-85. PubMed ID: 18786556
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 3-ylideneoxindole acetamides as potent anticancer agents.
Chiou CT; Lee WC; Liao JH; Cheng JJ; Lin LC; Chen CY; Song JS; Wu MH; Shia KS; Li WT
Eur J Med Chem; 2015 Jun; 98():1-12. PubMed ID: 25988923
[TBL] [Abstract][Full Text] [Related]
13. 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Ahn MY; Kim TH; Kwon SM; Yoon HE; Kim HS; Kim JI; Kim YC; Kang KW; Ahn SG; Yoon JH
Eur J Pharm Sci; 2015 Nov; 79():122-31. PubMed ID: 26342773
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
15. Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.
Choi SJ; Moon MJ; Lee SD; Choi SU; Han SY; Kim YC
Bioorg Med Chem Lett; 2010 Mar; 20(6):2033-7. PubMed ID: 20153646
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.
Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC
Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313
[TBL] [Abstract][Full Text] [Related]
17. Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines.
León LG; Donadel OJ; Tonn CE; Padrón JM
Bioorg Med Chem; 2009 Sep; 17(17):6251-6. PubMed ID: 19664930
[TBL] [Abstract][Full Text] [Related]
18. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.
Song JH; Lee JE; Cho KM; Park SH; Kim HJ; Kim YC; Kim TS
Mol Carcinog; 2016 May; 55(5):611-21. PubMed ID: 25788004
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of indirubin derivatives on the growth of HL-60 leukemia cells.
Cuong NM; Tai BH; Hoan DH; Huong TT; Kim YH; Hyun JH; Kang HK
Nat Prod Commun; 2010 Jan; 5(1):103-6. PubMed ID: 20184032
[TBL] [Abstract][Full Text] [Related]
20. Photoreactivity of indirubin derivatives.
Olivier D; Poincelot MA; Douillard S; Lefevre C; Moureau J; Ferandin Y; Bettayeb K; Xiao Z; Magiatis P; Skaltsounis L; Meijer L; Patrice T
Photochem Photobiol Sci; 2008 Mar; 7(3):328-36. PubMed ID: 18389150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
